US Patent Issued to ANTECIP BIOVENTURES II on June 23 for "Pharmaceutical compositions comprising bupropion and cysteine" (New York Inventor)

ALEXANDRIA, Va., July 15 -- United States Patent no. 12,661,408, issued on June 23, was assigned to ANTECIP BIOVENTURES II LLC (New York).

"Pharmaceutical compositions comprising bupropion and cysteine" was invented by Herriot Tabuteau (New York).

According to the abstract* released by the U.S. Patent & Trademark Office: "This disclosure relates to pharmaceutical compositions comprising bupropion and cysteine, and pharmaceutical dosage forms comprising bupropion and cysteine. The disclosure also relates to molecular complexes of bupropion and cysteine. These compositions and dosage forms may have improved stability of bupropion."

The patent was filed on June 13, 2025, under Application No. 19/238,194.

*For further information, including...